API Holdings Ltd.’s Acquisition of 66.1% Stake in Thyrocare Technologies

Trilegal and AZB & Partners advised API Holdings Ltd. on the deal, Shardul Amarchand Mangaldas & Co advised Thyrocare.

API Holdings Ltd., the parent company of PharmEasy, completed the acquisition of 66.1% stake in Thyrocare Technologies Ltd.

The Trilegal competition team representing API was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law; Harshita Parmar and Shambhvi Sinha, Senior Associates; and Akrathi Shetty and Rishi Kauntia, Associates.

AZB & Partners advised API with a team led by Anand Shah and Pranav Atit.

Shardul Amarchand Mangaldas & Co and JM Financial also advised API.

Shardul Amarchand Mangaldas & Co advised Thyrocare with a team led by Raghubir Menon.

Involved fees earner: Pranav Atit – Azb & partners; Anand Shah – Azb & partners; Raghubir Menon – Shardul Amarchand & Mangaldas & Co.; Rishi Kauntia – Trilegal; Harshita Parmar – Trilegal; Akrathi Shetty – Trilegal; Shambhvi Sinha – Trilegal; Nisha Kaur Uberoi – Trilegal;

Law Firms: Azb & partners; Shardul Amarchand & Mangaldas & Co.; Trilegal;

Clients: API Holdings ; Thyrocare Technologies ;

Author: Sonia Carcano